Cargando…

LDL receptor-peptide conjugate as in vivo tool for specific targeting of pancreatic ductal adenocarcinoma

Despite clinical advances in diagnosis and treatment, pancreatic ductal adenocarcinoma (PDAC) remains the third leading cause of cancer death, and is still associated with poor prognosis and dismal survival rates. Identifying novel PDAC-targeted tools to tackle these unmet clinical needs is thus an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Acier, Angélina, Godard, Magali, Gassiot, Fanny, Finetti, Pascal, Rubis, Marion, Nowak, Jonathan, Bertucci, François, Iovanna, Juan L., Tomasini, Richard, Lécorché, Pascaline, Jacquot, Guillaume, Khrestchatisky, Michel, Temsamani, Jamal, Malicet, Cédric, Vasseur, Sophie, Guillaumond, Fabienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8377056/ https://www.ncbi.nlm.nih.gov/pubmed/34413441 http://dx.doi.org/10.1038/s42003-021-02508-0

Ejemplares similares

Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos
por: David, Marion, et al.
Publicado: (2018)

Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions
por: Olivares, Orianne, et al.
Publicado: (2017)

p8 inhibits the growth of human pancreatic cancer cells and its expression is induced through pathways involved in growth inhibition and repressed by factors promoting cell growth
por: Malicet, Cédric, et al.
Publicado: (2003)

The metabolic facet of pancreatic cancer: How hypoxia shapes fatal cancer cells
por: Guillaumond, Fabienne, et al.
Publicado: (2013)

Lipids in cancer: a global view of the contribution of lipid pathways to metastatic formation and treatment resistance
por: Vasseur, Sophie, et al.
Publicado: (2022)

Gene expression profiling of tumours derived from ras(V12)/E1A-transformed mouse embryonic fibroblasts to identify genes required for tumour development
por: Vasseur, Sophie, et al.
Publicado: (2005)

Influence of the Tumor Microenvironment on Cancer Cells Metabolic Reprogramming
por: Gouirand, Victoire, et al.
Publicado: (2018)

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma
por: Siret, Carole, et al.
Publicado: (2018)

Gene expression profiling by DNA microarray analysis in mouse embryonic fibroblasts transformed by ras(V12 )mutated protein and the E1A oncogene
por: Vasseur, Sophie, et al.
Publicado: (2003)

Hypoxia Induced Tumor Metabolic Switch Contributes to Pancreatic Cancer Aggressiveness
por: Vasseur, Sophie, et al.
Publicado: (2010)

Lipid metabolic reprogramming in cancer cells
por: Beloribi-Djefaflia, S, et al.
Publicado: (2016)

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis
por: Mohamed Abd-El-Halim, Yousra, et al.
Publicado: (2021)

Immunologic constant of rejection as a predictive biomarker of immune checkpoint inhibitors efficacy in non-small cell lung cancer
por: Mogenet, Alice, et al.
Publicado: (2023)

Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling
por: Secq, V, et al.
Publicado: (2015)

Dissecting the Anticancer Mechanism of Trifluoperazine on Pancreatic Ductal Adenocarcinoma
por: Huang, Can, et al.
Publicado: (2019)

Basal Breast Cancer: A Complex and Deadly Molecular Subtype
por: Bertucci, F, et al.
Publicado: (2012)

The E2F4 prognostic signature is also predictive of the pathological response of breast cancer to chemotherapy
por: Bertucci, François, et al.
Publicado: (2015)

XPO1, therapeutic … and prognostic target in sarcomas
por: Bertucci, François, et al.
Publicado: (2016)

Masitinib Combined with Standard Gemcitabine Chemotherapy: In Vitro and In Vivo Studies in Human Pancreatic Tumour Cell Lines and Ectopic Mouse Model
por: Humbert, Martine, et al.
Publicado: (2010)

Pancreatic Ductal Adenocarcinoma: A Strong Imbalance of Good and Bad Immunological Cops in the Tumor Microenvironment
por: Foucher, Etienne D., et al.
Publicado: (2018)

A pancreatic ductal adenocarcinoma subpopulation is sensitive to FK866, an inhibitor of NAMPT
por: Barraud, Marine, et al.
Publicado: (2016)

The therapeutic response of ER+/HER2− breast cancers differs according to the molecular Basal or Luminal subtype
por: Bertucci, François, et al.
Publicado: (2020)

The CINSARC signature predicts the clinical outcome in patients with Luminal B breast cancer
por: Goncalves, Anthony, et al.
Publicado: (2021)

oxLDL and eLDL Induced Membrane Microdomains in Human Macrophages
por: Wallner, Stefan, et al.
Publicado: (2016)

Electronegative LDL: A Circulating Modified LDL with a Role in Inflammation
por: Estruch, Montserrat, et al.
Publicado: (2013)

Precipitated sdLDL: An easy method to estimate LDL particle size
por: Fernández‐Cidón, Bárbara, et al.
Publicado: (2020)

Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
por: Deng, Chang-Feng, et al.
Publicado: (2022)

Extending the GANIL control system for the SPIRAL project
por: Lecorché, E
Publicado: (1997)

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer
por: Bertucci, François, et al.
Publicado: (2023)

The MonarchE trial: improving the clinical outcome in HR(+)/HER2(−) early breast cancer: recent results and next steps
por: Bertucci, François, et al.
Publicado: (2023)

When LDL Cholesterol Is Not LDL Cholesterol: LpX, A Clinical Lesson
por: Huygen, Lisa P.M., et al.
Publicado: (2022)

Commentary: Involvement of LDL and ox-LDL in Cancer Development and Its Therapeutical Potential
por: Ravnskov, Uffe, et al.
Publicado: (2022)

The beneficial effects of nutraceuticals and natural products on small dense LDL levels, LDL particle number and LDL particle size: a clinical review
por: Talebi, Sepide, et al.
Publicado: (2020)

QTAIM and IRC studies for the evaluation of activation energy on the C=P, C=N and C=O Diels-Alder reaction
por: Hammoudan, Imad, et al.
Publicado: (2020)

Inhibitors of BMP‐1/tolloid‐like proteinases: efficacy, selectivity and cellular toxicity
por: Talantikite, Maya, et al.
Publicado: (2018)

A New Function for the LDL Receptor: Transcytosis of LDL across the Blood–Brain Barrier
por: Dehouck, Bénédicte, et al.
Publicado: (1997)

Early Transcriptomic Response to LDL and oxLDL in Human Vascular Smooth Muscle Cells
por: Damián-Zamacona, Salvador, et al.
Publicado: (2016)

Small Dense LDL Level and LDL/HDL Distribution in Acute Coronary Syndrome Patients
por: Otrante, Alyann, et al.
Publicado: (2023)

Exploring the Complementarity of Pancreatic Ductal Adenocarcinoma Preclinical Models
por: Hoare, Owen, et al.
Publicado: (2021)

Combining the antianginal drug perhexiline with chemotherapy induces complete pancreatic cancer regression in vivo
por: Reyes-Castellanos, Gabriela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_v81f4ujhjnsuff41d5rtb2lds0